#China #Neusoft #Shenyang #photon-counting CT #NeuViz P10

Neusoft Medical Systems Launches China's First Photon-Counting CT

Neusoft Medical Systems has just announced a significant milestone in the medical imaging sector with its recent approval of the NeuViz P10 photon-counting CT scanner by China's National Medical Products Administration (NMPA). This innovative device represents not only the first of its kind in China but also the world's foremost wide-body system equipped with an impressive 8-cm detector.

The NeuViz P10 utilizes cutting-edge technology that redefines conventional imaging methods. Unlike traditional CT scanners, which create images by first converting X-rays into light before digitization, this revolutionary system employs a cadmium zinc telluride (CZT) detector. This unique approach allows for the direct capture and conversion of each X-ray photon into digital signals, resulting in image quality that surpasses current standards.

Enhanced Imaging Quality and Patient Safety

The advantages of photon-counting CT are manifold. Primarily, the technology promises clearer images, making it significantly easier for healthcare professionals to visualize intricacies such as small blood vessels, crucial for conditions like cardiac disease. Furthermore, this technology enables the early detection of tumors that are otherwise challenging to see and enhances the identification of neurological conditions.

Another critical benefit is the reduction in radiation exposure for patients. By focusing on superior image quality at lower doses, the NeuViz P10 offers a safer option for lung examinations, paving the way for increased patient safety without sacrificing diagnostic capabilities.

Key Innovations in Clinical Value

To fully leverage its clinical and research potential, the NeuViz P10 integrates four innovative platforms: NeuPhoton Counting, Photon Supersonic, Photon Intelligence, and Photon Research. These platforms work synergistically to provide faster scans and improved imaging while incorporating intelligent workflow capabilities that enhance the overall clinical experience.

As Patrick Wu, CEO of Neusoft Medical Systems, stated, "The approval of NeuViz P10 is a milestone for China's medical imaging industry and for global CT innovation. This technology empowers radiologists with clearer images at lower doses, giving patients earlier and more accurate answers while delivering maximum clinical value for public health." This sentiment underscores the transformative impact this technology could have on both practitioners and patients alike.

Neusoft Medical Systems: A Leader in Innovation

Founded with the vision to integrate artificial intelligence into medical imaging, Neusoft Medical Systems is at the forefront of healthcare technology. The company is committed to creating intelligent, efficient, and reliable products and services that not only enhance medical practices but also improve patient outcomes.

By the end of 2024, Neusoft Medical Systems proudly established a presence in over 120 countries, serving more than 14,000 clients and boasting a remarkable installed base exceeding 50,000 units. This global reach signifies the company’s dedication to enhancing accessibility and equity in healthcare worldwide.

Conclusion

In summary, the introduction of the NeuViz P10 photon-counting CT not only represents a leap forward for Neusoft Medical Systems but also positions China at the forefront of medical imaging innovation. With its groundbreaking technology, the NeuViz P10 is set to enhance diagnostic accuracy, improve patient safety, and alter the course of traditional imaging practices as we know them today. As healthcare continues to evolve, so too will the technologies that empower it, ensuring a brighter future for both patients and practitioners.